In the news – Page 3 – ONK Therapeutics

Maximizing synergy and mitigating resistance: novel dual-targeted natural killer cell therapies for cancer

01/03/2021

Nature BioPharma Dealmaker – View full story

ONK and Anthony Nolan combine forces to work on blood cancer therapies

22/02/2021

Pharmafile – View full story

ONK Therapeutics enters collaboration with blood cancer charity Anthony Nolan

22/02/2021

Pharma Times – View full story

ONK’s CAR NK cells hit the TRAIL

23/01/2021

Biocentury – View full story (behind paywall)

European Cancer Deals Increasingly Focus on Natural Killer Cells

30/10/2020

Labiotech – View full story

Mulligan backs ONK Therapeutics in $8m funding

19/10/2020

The Irish Times – View full story

Kite’s former EU chief Nowers joins NK cell startup ONK as CEO

19/10/2020

Fierce Biotech – View full story

CAR-plus: Irish biotech recruits Kite alum Chris Nowers to prep dual-targeting NK cell therapy for the clinic

19/10/2020

Endpoints – View full story

Irish pharma deal hopes to significantly improve cancer treatment

16/05/2020

The Irish Times – View full story